π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a randomized, controlled, multicenter clinical study that enrolled ...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2026-05-01
Trial ID
NCT07560358
The study is a multicenter, open-label, randomized controlled clinical stud...
Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-07-20
Trial ID
NCT04928807
Treatments Being Tested
This is a phase II/III, multi-center, open-label, 3-arm, randomized control...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2022-04-01
Trial ID
NCT05245474
Treatments Being Tested
This is a multicenter, randomized, controlled phase III trial to evaluate t...
Status
Suspended
Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Start Date
2023-12-01
Trial ID
NCT06246344
A Phase II Study of Serplulimab Plus Chemoradiotherapy as Adjuvant Treatmen...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2024-11-19
Trial ID
NCT06727617
Treatments Being Tested
This research aims to explore the therapeutic effect of neoadjuvant chemoth...
Status
Completed
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2015-09
Trial ID
NCT02861196
Treatments Being Tested
The combination of chemotherapy with radiotherapy remains the standard of t...
Status
Terminated
Location
University Hospital of Crete
Start Date
2006-03
Trial ID
NCT00431613
Treatments Being Tested
This trial will study the safety and tolerability and disease survival rate...
Status
Recruiting
Location
UPMC Hillman Cancer
Start Date
2026-04-06
Trial ID
NCT07423078
Treatments Being Tested
Currently, adjuvant therapy is not recommended for patients with esophageal...
Status
Recruiting
Location
Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC)
Start Date
2018-11-01
Trial ID
NCT03731442
Treatments Being Tested
Rationale: Completely resected non-small cell lung cancer (NSCLC) patients ...
Status
Terminated
Location
Shanghai Chest Hospital
Start Date
2016-11
Trial ID
NCT02974426